White blood cell counts as risk markers of developing metabolic syndrome and its components in the PREDIMED study.

<h4>Background</h4>The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for...

Full description

Bibliographic Details
Main Authors: Nancy Babio, Núria Ibarrola-Jurado, Mònica Bulló, Miguel Ángel Martínez-González, Julia Wärnberg, Itziar Salaverría, Manuel Ortega-Calvo, Ramón Estruch, Lluís Serra-Majem, Maria Isabel Covas, José Vicente Sorli, Jordi Salas-Salvadó, PREDIMED Study Investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23526980/pdf/?tool=EBI